Table 1.
Baseline, demographic, and disease-related parameters in childhood-onset Takayasu arteritis (c-TA).
| Control(n=5) | Exercise training(n=9) | P | |
|---|---|---|---|
| Demographic parameters | |||
| Age (years) | 20.4 (3.21) | 17.1 (3.72) | 0.822 |
| Height (m) | 1.68 (0.16) | 1.57 (0.05) | 0.003 |
| Body weight (kg) | 58.7 (13.5) | 55.2 (10.4) | 0.486 |
| BMI (kg/m2) | 20.4 (1.96) | 22.2 (3.39) | 0.257 |
| Female, n (%) | 2 (40) | 8 (88.8) | 0.094 |
| Disease time (years), n (%) | 12.6 (2.97) | 8.56 (3.17) | 0.963 |
| Age at the disease onset (years) | 7.80 (5.07) | 8.56 (3.17) | 0.420 |
| Arterial hypertension, n (%) | 3 (60) | 9 (100) | 0.109 |
| Infliximab, n (%) | 0 (0) | 2 (22.2) | 0.505 |
| Adalimumab, n (%) | 1 (20) | 1 (11.1) | 1.000 |
| Leflunomide, n (%) | 2 (40) | 0 (0) | 0.505 |
| Methotrexate, n (%) | 1 (20) | 5 (55.5) | 0.307 |
| Prednisone, n (%) | 1 (20) | 1 (11.1) | 1.000 |
| ITAS score (a.u.) | 0.00 (0.00-0.50) | 0.00 (0.00-0.50) | N/A |
| PVAS score (a.u.) | 0.00 (0.00-1.00) | 0.00 (0.00-0.50) | N/A |
| VDI score (a.u.) | 2.00 (2.00-2.50) | 1.00 (2.00-2.50) | N/A |
| SUV grade I | 47.3 (21.9) | 32.5 (24.9) | 0.907 |
| SUV grade II | 44.7 (22.1) | 56.1 (27.1) | 0.798 |
| SUV grade III | 7.9 (6.8) | 11.2 (9.9) | 0.579 |
Data are expressed as mean (SD), n (%) or median (IQR 25-75). BMI, body mass index; ITAS, indian takayasu's arteritis activity score 2010; PVAS, Pediatric Vasculitis Activity Score; VDI, vascular damage index; SUV, standard uptake value.